Vaxabov B.M. HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES. jasass [Internet]. 2025 Dec. 16 [cited 2026 May 25];15(12):627-30. Available from: https://www.internationaljournal.co.in/index.php/jasass/article/view/2669